It is a financial services private limited company based in Andhra Pradesh, Telangana, India, established in 1989.
1989 | Andhra Pradesh, Telangana, India | ActiveNauge Pharmaceuticals Pvt Ltd, a active private limited company, was established on 02 February 1989 in Andhra Pradesh, Telangana, India. Engaging in real estate financing within the manufacturing sector, it holds CIN: U24230TG1989PTC009568. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.79 M.
It upholds a compliant status. Employing 6 professional, Its leadership includes Priyanandana Varma Mudunuri (Director), Venkata Krishna Satyanarayana Raju Kanumuru (Director), Sailaja Rudraraju (Director). Past directors included Suresh Kumar Manchanda, Priyanandana Varma Mudunuri, Balarama Murty Raju Mudunuri. It holds ₹5.00 Cr open charges and ₹5.00 Cr settled loans. Its latest AGM occurred on 25 August 2025, with the balance sheet filed on 31 March 2025. It is based at # 17D, Phase 1, Ida,Patancheruvu, Hyderabad, Andhra Pradesh, Telangana, 502319.
U24230TG1989PTC009568
009568
02 February 1989
₹5.00 M
₹4.79 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Nauge Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priyanandana Varma Mudunuri | Director | 16 Oct 2023 | Current |
| Venkata Krishna Satyanarayana Raju Kanumuru | Director | 29 Oct 2002 | Current |
| Sailaja Rudraraju | Director | 29 Oct 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Feb 2015 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 28 Feb 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nauge Pharmaceuticals Pvt Ltd, for the financial year ended 2021, experienced modest growth in revenue, with a 1.93% increase. The company also saw a substantial fall in profitability, with a 29.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.46%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Nauge Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹50,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jul 2003 | State Bank Of India | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nauge Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nauge Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nauge Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nauge Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 25 Aug 2025 as per latest MCA records. was documented.
The activity Nauge Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
The activity A charge registered on 17 Jul 2003 via Charge ID 90119902 with State Bank Of India was fully satisfied on 10 Feb 2025. was completed.
Progress on Priyanandana Varma Mudunuri was appointed as a Director was appointed as a Director on 16 Oct 2023 & has been associated with this company since 2 years 1 month . was documented.
The activity A charge with State Bank Of India of Rs. 50.00 M registered on 17 Jul 2003 with Charge ID 90119902 was modified on 31 May 2006. was completed.
The activity A charge with State Bank Of India amounted to Rs. 50.00 M with Charge ID 90119902 was registered on 17 Jul 2003. was completed.
The CIN of Nauge Pharmaceuticals Pvt Ltd is U24230TG1989PTC009568.
Nauge Pharmaceuticals Pvt Ltd is headquartered at # 17D, Phase 1, Ida,Patancheruvu, Hyderabad, Andhra Pradesh, Telangana, 502319.
Nauge Pharmaceuticals Pvt Ltd was incorporated on 02 February 1989.
The current directors of Nauge Pharmaceuticals Pvt Ltd are
The primary industry of Nauge Pharmaceuticals Pvt Ltd is Manufacturing.
Nauge Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Nauge Pharmaceuticals Pvt Ltd is ₹5.00 M, and the paid-up capital is ₹4.79 M.
The compliance status of Nauge Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX